Trust Chem Co., Ltd.
001335
ESKONJAC
839273
Hunan Lead Power Technology Group
300530
4
Tongling Jieya Biologic Technology
301108
5
Nantong Jiangtian Chemical
300927
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 32.73%-5.73M | 23.06%-1.37M | 24.80%-1.41M | 47.25%-1.29M | 31.33%-1.67M | 4.57%-8.51M | 20.34%-1.77M | 32.50%-1.87M | -39.27%-2.44M | -11.90%-2.43M |
Net income from continuing operations | 31.40%-5.66M | 34.15%-1.48M | 18.69%-1.43M | 40.42%-1.27M | 30.01%-1.48M | 18.34%-8.24M | 0.49%-2.24M | 31.89%-1.76M | 29.59%-2.13M | 5.54%-2.12M |
Depreciation and amortization | 93.41%352K | 480.85%273K | -97.73%1K | -31.91%32K | 4.55%46K | 4.60%182K | 4.44%47K | -2.22%44K | 11.90%47K | 4.76%44K |
Change In working capital | -33.64%-1.01M | -267.77%-557K | 74.38%-52K | 74.04%-115K | 35.84%-281K | -224.30%-752K | 355.38%332K | 41.33%-203K | -139.66%-443K | -1,116.67%-438K |
-Change in receivables | 256.72%105K | -129.17%-55K | 105.93%7K | 20.45%53K | 222.58%100K | -6,800.00%-67K | -700.00%-24K | -3,833.33%-118K | 46.67%44K | 203.33%31K |
-Change in inventory | 10.67%83K | -47.14%74K | -41.67%35K | 73.33%-12K | 82.50%-14K | 117.28%75K | 237.25%140K | -16.67%60K | 88.34%-45K | -344.44%-80K |
-Change in prepaid assets | 184.78%78K | 85.00%-15K | -195.83%-46K | 226.32%62K | 230.51%77K | -116.49%-92K | -204.17%-100K | -28.36%48K | -91.36%19K | -133.71%-59K |
-Change in payables and accrued expense | -84.62%-936K | -179.56%-288K | 79.05%-31K | 46.88%-221K | -29.84%-396K | -178.85%-507K | 320.73%362K | 57.10%-148K | -132.53%-416K | -140.16%-305K |
-Change in other current assets | --34K | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
-Change in other current liabilities | -129.19%-369K | -493.48%-273K | 62.22%-17K | 31.11%-31K | -92.00%-48K | 9.55%-161K | -6.98%-46K | 22.41%-45K | -9.76%-45K | 30.56%-25K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 32.73%-5.73M | 23.06%-1.37M | 24.80%-1.41M | 47.25%-1.29M | 31.33%-1.67M | 4.57%-8.51M | 20.34%-1.77M | 32.50%-1.87M | -39.27%-2.44M | -11.90%-2.43M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | 0 | -972.73%-118K | 0 | 0 | -24K | -1,466.67%-94K |
Net PPE purchase and sale | --0 | --0 | --0 | --0 | --0 | -972.73%-118K | --0 | --0 | ---24K | -1,466.67%-94K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | --0 | --0 | --0 | --0 | -972.73%-118K | --0 | --0 | ---24K | -1,466.67%-94K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -49.08%4.33M | 1.18M | -102.21%-97K | 7,627.27%3.31M | -101.46%-61K | 1,711.17%8.51M | 0 | 7,723.21%4.38M | -44K | 4.17M |
Net common stock issuance | -48.50%4.38M | --1.12M | -99.65%15K | --3.25M | --0 | --8.51M | --0 | --4.32M | --0 | --4.19M |
Net other financing activities | ---49K | --63K | ---- | ---- | -190.48%-61K | ---- | ---- | ---- | ---44K | ---21K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -49.08%4.33M | --1.18M | -102.21%-97K | 7,627.27%3.31M | -101.46%-61K | 1,711.17%8.51M | --0 | 7,723.21%4.38M | ---44K | --4.17M |
Net cash flow | ||||||||||
Beginning cash position | -3.47%3.4M | -57.65%2.19M | 38.89%3.69M | -67.72%1.67M | -3.47%3.4M | -72.89%3.52M | -18.32%5.17M | -70.62%2.66M | -52.16%5.17M | -72.89%3.52M |
Current changes in cash | -1,041.80%-1.39M | 89.46%-187K | -159.92%-1.5M | 180.74%2.03M | -204.67%-1.73M | 98.71%-122K | 36.89%-1.77M | 192.25%2.51M | -43.15%-2.51M | 175.90%1.65M |
End cash Position | -41.03%2M | -41.03%2M | -57.65%2.19M | 38.89%3.69M | -67.72%1.67M | -3.47%3.4M | -3.47%3.4M | -18.32%5.17M | -70.62%2.66M | -52.16%5.17M |
Free cash flow | 33.65%-5.73M | 23.06%-1.37M | 24.80%-1.41M | 47.77%-1.29M | 33.89%-1.67M | 3.37%-8.63M | 20.34%-1.77M | 32.63%-1.87M | -40.64%-2.46M | -15.92%-2.52M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |